Conţinutul numărului revistei |
Articolul precedent |
Articolul urmator |
204 0 |
SM ISO690:2012 DAGRES, Nikolaos, NIEUWLAAT, Robby, VARDAS, Panos E., VATAMAN, Eleonora, GROSU, Aurel, NOI, Autori. Gender-Related Differences in Presentation, Treatment, and Outcome of Patients With Atrial Fibrillation in Europe. A Report From the Euro Heart Survey on Atrial Fibrillation. In: Journal of the American College of Cardiology, 2007, vol. 49, pp. 572-577. ISSN 0735-1097. DOI: https://doi.org/10.1016/j.jacc.2006.10.047 |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
Journal of the American College of Cardiology | ||||||
Volumul 49 / 2007 / ISSN 0735-1097 /ISSNe 1558-3597 | ||||||
|
||||||
DOI:https://doi.org/10.1016/j.jacc.2006.10.047 | ||||||
Pag. 572-577 | ||||||
|
||||||
Rezumat | ||||||
Objectives: This study sought to investigate gender-related differences in patients with atrial fibrillation (AF) in Europe. Background: Gender-related differences may play a significant role in AF. Methods: We analyzed the data of 5,333 patients (42% female) enrolled in the Euro Heart Survey on Atrial Fibrillation. Results: Compared with men, the women were older, had a lower quality of life (QoL), had more comorbidities, more often had heart failure (HF) with preserved left ventricular systolic function (18% vs. 7%, p < 0.001), and less often had HF with systolic dysfunction (17% vs. 26%, p < 0.001). Among patients with typical AF symptoms (56% of women, 49% of men), there was no gender-related difference in the choice of rate or rhythm control. Among patients with atypical or no symptoms (44% of women, 51% of men), women less frequently underwent rhythm control (39% vs. 51%, p < 0.001) than did men. Women underwent less electrical cardioversion (22% vs. 28%, p < 0.001). Prescription of oral anticoagulants was identical (65%) in both genders. One-year outcome was similar except that women had a higher chance for stroke (odds ratio 1.83 in multivariable regression analysis, p = 0.019). Conclusions: Women with AF had more comorbidities, more HF with preserved systolic function, and a lower QoL than men. In the large group with atypical or no symptoms, women were treated appropriately more conservatively with less rhythm control than men. Women had a higher chance for stroke. Long-term QoL changes and other morbidities and mortality were similar. |
||||||
Cuvinte-cheie EMTREE drug terms acetylsalicylic acid, amiodarone, antiarrhythmic agent, anticoagulant agent, beta adrenergic receptor blocking agent, clopidogrel, digitoxin, digoxin, heparin, Low molecular weight heparin, sotalol, ticlopidine EMTREE medical terms adult, Aged, article, artificial heart pacemaker, cardioversion, clinical feature, comorbidity, drug use, Europe, female, heart atrium fibrillation, heart failure, heart left ventricle function, human, major clinical study, Male, mortality, outcome assessment, priority journal, quality of life, sex difference, stroke, thromboembolism |
||||||
|
Google Scholar Export
<meta name="citation_title" content="Gender-Related Differences in Presentation, Treatment, and Outcome of Patients With Atrial Fibrillation in Europe. A Report From the Euro Heart Survey on Atrial Fibrillation"> <meta name="citation_author" content="Dagres Nikolaos"> <meta name="citation_author" content="Nieuwlaat Robby"> <meta name="citation_author" content="Vardas Panos E."> <meta name="citation_author" content="Vataman Eleonora"> <meta name="citation_author" content="Grosu Aurel"> <meta name="citation_author" content="Noi Autori"> <meta name="citation_publication_date" content="2007/02/06"> <meta name="citation_journal_title" content="Journal of the American College of Cardiology"> <meta name="citation_firstpage" content="572"> <meta name="citation_lastpage" content="577"> <meta name="citation_pdf_url" content="https://www.scopus.com/record/display.uri?eid=2-s2.0-33846635888&doi=10.1016%2fj.jacc.2006.10.047&origin=inward&txGid=a16c9daac7d8c9b27559ba8e0cad8498">